Treatment of Myelodysplastic Syndromes with Hematopoietic Growth Factors
- 1 June 1992
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 6 (3) , 633-653
- https://doi.org/10.1016/s0889-8588(18)30333-2
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessmentAnnals of Hematology, 1992
- In vivo administration of granulocyte‐macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromesBritish Journal of Haematology, 1991
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991
- Regulation of mRNA levels of alkaline phosphatase gene in neutrophilic granulocytes by granulocyte colony-stimulating factor and retinoic acidEuropean Journal of Haematology, 1991
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSFInternational Journal of Cancer, 1990
- Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factorThe International Journal of Cell Cloning, 1990
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary reportThe American Journal of Medicine, 1989
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987